MedPath

Antimicrobial Pulpotomy of Primary Molars

Phase 4
Completed
Conditions
Inflammation
Necrosis
Interventions
Procedure: Antimicrobial pulpotomy
Procedure: Calcium hydroxide pulpectomy
Registration Number
NCT01010451
Lead Sponsor
Universidade Federal de Goias
Brief Summary

There is a lack of evidence of the long-term successful outcomes of antimicrobial endodontic treatment for primary teeth. This study intended to evaluate (by survival analysis) the effectiveness of an antimicrobial pulpotomy (chloramphenicol, tetracycline, zinc oxide/eugenol) in primary molars compared to calcium hydroxide pulpectomy, testing the hypothesis that antimicrobial pulpotomy could be an alternative pulp therapy for primary teeth with pulp inflammation or necrosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Healthy children (ASA PS 1)
  • Children presenting one or more primary molar with pulp inflammation or necrosis due to carious lesion and indicated for endodontic therapy
Exclusion Criteria
  • Lost to follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Antimicrobial pulpotomyAntimicrobial pulpotomyPulpotomy of primary molars with pulp inflammation or necrosis due to carious lesions using an antimicrobial paste
Calcium hydroxide pulpectomyCalcium hydroxide pulpectomyPulpectomy of primary molars with pulp inflammation or necrosis due to carious lesions using a calcium hydroxide paste as intracanal medication
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dental School

🇧🇷

Goiânia, Goiás, Brazil

© Copyright 2025. All Rights Reserved by MedPath